PharmaCyte Biotech (PMCB) Net Income (2010 - 2026)
PharmaCyte Biotech (PMCB) recorded Net Income of -$840,430 in fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$630,512 a year earlier.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Net Income (2010 - 2026) Analysis & Trends
On a TTM basis, PharmaCyte Biotech's Net Income came in at -$6.33 million as of Jul 31, 2026; for FY2026 (ended Apr 30, 2026), it came in at -$6.12 million.
- Across earlier fiscal years, Net Income came in at -$2.96 million in FY2025, -$5.12 million in FY2024, -$4.52 million in FY2023 and -$4.23 million in FY2022.
- Quarterly Net Income has ranged from -$2.43 million in fiscal Q4 2026 to -$180,346 in fiscal Q4 2023 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$2.43 million (Q4 2026), -$1.89 million (Q3 2026) and -$1.17 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.75 Bn | 1,113.34 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 635.80 Bn | 555.66 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 502.77 Bn | 475.88 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.48 Bn | 310.86 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 301.04 Bn | 265.03 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 264.46 Bn | 238.15 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 238.99 Bn | 194.39 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.94 Bn | 169.14 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 170.77 Bn | 117.42 Bn | 10.94 Bn | -248.00 Mn |
| 10 | PharmaCyte Biotech | 3.67 Mn | -69.17 Mn | - | -5.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -5.08 Mn |
| Apr 30, 2026 | -4.39 Mn |
| Jan 31, 2026 | 746,860.00 |
| Oct 31, 2025 | -7.42 Mn |
| Jul 31, 2025 | -8.36 Mn |
| Apr 30, 2025 | 11.75 Mn |
| Jan 31, 2025 | -3.05 Mn |
| Oct 31, 2024 | -1.47 Mn |
| Jul 31, 2024 | 23.42 Mn |
| Apr 30, 2024 | 1.35 Mn |
| Jan 31, 2024 | -619,537.00 |
| Oct 31, 2023 | 2.79 Mn |
| Jul 31, 2023 | -3.18 Mn |
| Apr 30, 2023 | -126,338.00 |
| Jan 31, 2023 | -764,136.00 |
| Oct 31, 2022 | -1.88 Mn |
| Jul 31, 2022 | -1.55 Mn |
| Apr 30, 2022 | -1.42 Mn |
| Jan 31, 2022 | -811,290.00 |
| Oct 31, 2021 | -979,746.00 |
API Access
PharmaCyte Biotech Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();